| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |